Remove 2023 Remove Clinic Remove Disease
article thumbnail

DL algorithm targeting prostate cancer demonstrates clinical impact

AuntMinnie

When radiologists interpretations are indeterminate, a commercially available deep learning algorithm could find clinically significant prostate cancer with improved specificity while maintaining sensitivity, suggested research published March 11 in Radiology. A majority (179) of participants underwent multiparametric MRI, the authors noted.

Clinic 230
article thumbnail

PET links depressive symptoms to Alzheimer’s brain pathology

AuntMinnie

Columbia University researchers in New York City have reported that worsening depression in older adults is related to higher levels of Alzheimers disease pathology, specifically the accumulation of tau protein. The study was published April 9 in the American Journal of Geriatric Psychiatry. The full study can be found here.

PET Scan 215
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

AI-guided POCUS bests experts in detecting TB in underserved areas

AuntMinnie

AI-guided point-of-care ultrasound (POCUS) can accurately detect tuberculosis (TB), according to research presented April 14 at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) conference in Vienna, Austria. The technology may have applications in clinically underserved areas, Suttels said.

article thumbnail

Metabolic MRI technique shows promise in Alzheimer’s patients

AuntMinnie

Deuterium metabolic imaging (DMI) was highly aligned with F-18 FDG-PET -- a cornerstone of dementia diagnostics -- in patients with Alzheimer's disease in a study published April 8 in Radiology. They compared the DMI results to clinical FDG-PET data from patient records. A graphical abstract of the study. Image courtesy of RSNA.

MRI 215
article thumbnail

PET reveals patient responses to new Alzheimer’s disease drug

AuntMinnie

Patients with less tau pathology on PET scans may respond better to treatment with the new Alzheimer’s disease drug donanemab, according to an October 25 news report in the journal Practical Neurology. Food and Drug Administration, with a decision expected by the end of 2023. Donanemab is currently under review for approval by the U.S.

Disease 298
article thumbnail

Road to RSNA 2023: AI Preview

AuntMinnie

Welcome to the first installment of this year’s Road to RSNA preview of the RSNA 2023 meeting. AI’s capability and potential to enhance the practice of radiology will take center stage at RSNA 2023. For more information on those presentations and other abstracts, check out the RSNA 2023 meeting program. 9:40 a.m. | 9:40 a.m. |

article thumbnail

Minnies winners for 2023 highlight AI, innovation in radiology

AuntMinnie

And 2023 is no exception. The technology figured prominently in five Minnies categories, including Hottest Clinical Procedure. Workforce shortages were deemed by our Expert Panel to be the biggest threat in 2023. Each year, the Minnies award winners reflect the current challenges, issues, and advances in radiology.

Radiology 331